1 |
Camacho PM, Dwarkanathan AA. Sick euthyroid syndrome. What to do when thyroid function tests are abnormal in critically ill patients. Postgrad Med 1999;105:215-9
PUBMED
ScienceOn
|
2 |
Eberhard BA, Andersson U, Laxer RM, Rose V, Silverman ED. Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J 1995;14:199-203
DOI
PUBMED
ScienceOn
|
3 |
Lee H, Kim H, Kim HS, Sohn S. NT-proBNP: a new diagnostic screening tool for Kawasaki disease. Korean J Pediatr 2006;49:539-44
DOI
|
4 |
Brokhin M, Klein I. Low T3 syndrome in a patient with acute myocarditis. Clin Cornerstone 2005;7 Supple 2:528-9
|
5 |
Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003; 107:708-13
DOI
ScienceOn
|
6 |
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-9
DOI
PUBMED
ScienceOn
|
7 |
Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum 3,5,3'- triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab 1993;77:1695-9
DOI
ScienceOn
|
8 |
Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992; 121:924-6
DOI
|
9 |
Lin CY, Lin CC, Hwang B, Chiang BN. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 1993;152:309-12
DOI
ScienceOn
|
10 |
Hashimoto H, Igarashi N, Yachie A, Miyawaki T, Sato T. The Relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection. J Clin Endocrinol Metab 1994;78:288-91
DOI
ScienceOn
|
11 |
Belgorosky A, Weller G, Chaler E, Iorcansky S, Rivarola MA. Evaluation of serum total thyroxine and triiodothyronine and their serum fractions in nonthyroidal illness secondary to congenital heart disease. Studies before and after surgery. J Endocrinol Invest 1993;16:499-503
PUBMED
ScienceOn
|
12 |
Chopra IJ, Sakane S, Teco GN. A study of the serum concentration of tumor necrosis factor-alpha in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metab 1991;72:1113- 6
DOI
|
13 |
Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumor necrosis factor- and interleukin 6 in serum. Eur J Pediatr 1992;151:44-7
DOI
ScienceOn
|
14 |
McIver B, Gorman CA. Euthyroid sick syndrome: an overview. Thyroid 1997;7:125-32
DOI
ScienceOn
|
15 |
Pinelli M, Bindi M, Cassetti G, Moroni F, Pandolfo C, Rosada J, et al. Relationship between low T3 syndrome and NT- proBNP levels in non-cardiac patients. Acta Cardiol 2007; 62:19-24
DOI
ScienceOn
|
16 |
Ueno Y, Takano N, Kanegane H, Yokoi T, Yachie A, Miyawaki T, et al. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol 1989;76:337-42
|
17 |
Muta H, Ishii M, Egami K, Furui J, Sugahara Y, Akagi T, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr 2004;144:496-9
DOI
ScienceOn
|
18 |
Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, 1984
|
19 |
Hashimoto H, Igarashi N, Yachie A, Miyawaki T, Hashimoto T, Sato T. The relationship between serum levels of interleukin-6 and thyroid hormone during the follow-up study in children with nonthyroidal illness: marked inverse correlation in Kawasaki and infectious disease. Endocr J 1996;43;31-8
DOI
ScienceOn
|
20 |
van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990; 71:1567-72
DOI
|
21 |
Davies PH, Black EG, Sheppard MC, Franklyn JA. Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness. Clin Endocrinol (Oxf) 1996;44:199-205
DOI
|
22 |
Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47:232-4
DOI
ScienceOn
|
23 |
Boelen A, Maas MA, Lowik CW, Platvoet MC, Wiersinga WM. Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3'- triiodothyronine syndrome. Endocrinology 1996;137:5250-4
DOI
ScienceOn
|
24 |
Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS. Tumor necrosis factor- levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 2003; 44:1021-6
PUBMED
|
25 |
Pesce MA. Reference ranges for laboratory tests and procedures. In : Kliegman RM, Behrman RE, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia : WB Saunders Co, 2007:2943-54
|